文献速递湿疹皮炎与荨麻疹

迈向失禁相关性皮炎(IAD)的国际语言:根特全球IAD分类工具(GLOBIAD)在30个国家的设计与心理测量学特性评价

Towards an international language for incontinence-associated dermatitis (IAD): design and evaluation of psychometric properties of the Ghent Global IAD Categorization Tool (GLOBIAD) in 30 countries.
PubMed 文献 · Br J Dermatol · 2018-04-19

基于13国34名专家的三轮德尔菲法设计根特全球IAD分类工具(GLOBIAD),并在30国823名医护人员中用IAD照片测试其心理测量学特性。GLOBIAD分为持续红斑(类别1)和皮肤缺失(类别2),各按感染临床征象细分。区分两类的一致性0.86(95%CI 0.86-0.87),敏感度90%、特异度84%。结论认为GLOBIAD是系统性评估IAD的重要进展,但需进一步验证。

要点

  • GLOBIAD基于持续红斑(类别1)和皮肤缺失(类别2)分为两类,各按感染征象细分。
  • 区分类别1与类别2的敏感度90%、特异度84%,一致性0.86(95%CI 0.86-0.87)。
  • 总体一致性0.55(95%CI 0.55-0.56),总体Fleiss kappa 0.41(95%CI 0.41-0.41)。

核心结论

  • GLOBIAD的制定是迈向全球临床实践和研究中更系统评估IAD的重要一步,但需进一步验证。

研究设计与样本

  • 设计基于专家咨询,采用三轮德尔菲法,纳入来自13个国家的34名专家。
  • 在来自30个国家的823名医护人员样本中,使用反映不同严重程度的IAD照片测试该工具。
  • 评估诊断准确性(敏感度和特异度)、一致性、评定者间信度(多评定者Fleiss kappa)和评定者内信度(Cohen's kappa)。

主要发现

  • GLOBIAD由两个类别组成:基于持续红斑存在的类别1和基于皮肤缺失存在的类别2,两者均根据感染临床征象的存在进一步细分。
  • 区分类别1与类别2的一致性为0.86(95%CI 0.86-0.87),敏感度为90%,特异度为84%。
  • 总体一致性为0.55(95%CI 0.55-0.56)。
  • 区分类别1与类别2的Fleiss kappa为0.65(95%CI 0.65-0.65),总体Fleiss kappa为0.41(95%CI 0.41-0.41)。
  • 区分类别1与类别2的Cohen's kappa为0.76(95%CI 0.75-0.77),总体Cohen's kappa为0.61(95%CI 0.59-0.62)。

关键数值与推荐

  • 类别1基于持续红斑的存在,类别2基于皮肤缺失的存在,两类均按感染临床征象细分。
  • 区分类别1与类别2的敏感度为90%,特异度为84%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文结论指出需进一步验证(further validation is needed)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Incontinence-associated dermatitis (IAD) is a specific type of irritant contact dermatitis with different severity levels. An internationally accepted instrument to assess the severity of IAD in adults, with established diagnostic accuracy, agreement and reliability, is needed to support clinical practice and research. OBJECTIVES: To design the Ghent Global IAD Categorization Tool (GLOBIAD) and evaluate its psychometric properties. METHODS: The design was based on expert consultation using a three-round Delphi procedure with 34 experts from 13 countries. The instrument was tested using IAD photographs, which reflected different severity levels, in a sample of 823 healthcare professionals from 30 countries. Measures for diagnostic accuracy (sensitivity and specificity), agreement, interrater reliability (multirater Fleiss kappa) and intrarater reliability (Cohen's kappa) were assessed. RESULTS: The GLOBIAD consists of two categories based on the presence of persistent redness (category 1) and skin loss (category 2), both of which are subdivided based on the presence of clinical signs of infection. The agreement for differentiating between category 1 and category 2 was 0·86 [95% confidence interval (CI) 0·86-0·87], with a sensitivity of 90% and a specificity of 84%. The overall agreement was 0·55 (95% CI 0·55-0·56). The Fleiss kappa for differentiating between category 1 and category 2 was 0·65 (95% CI 0·65-0·65). The overall Fleiss kappa was 0·41 (95% CI 0·41-0·41). The Cohen's kappa for differentiating between category 1 and category 2 was 0·76 (95% CI 0·75-0·77). The overall Cohen's kappa was 0·61 (95% CI 0·59-0·62). CONCLUSIONS: The development of the GLOBIAD is a major step towards a better systematic assessment of IAD in clinical practice and research worldwide. However, further validation is needed.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Beeckman D, Van den Bussche K, Alves P, et al. Towards an international language for incontinence-associated dermatitis (IAD): design and evaluation of psychometric properties of the Ghent Global IAD Categorization Tool (GLOBIAD) in 30 countries. Br J Dermatol. 2018. PMID: 29315488. doi:10.1111/bjd.16327

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。